Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumos Labs is a pioneer in digital brain health. Its flagship product "Lumosity" is widely used by consumers to train and assess cognitive abilities. The company has developed validated assessment tools like the NCPT and collaborates with academic partners globally through the Human Cognition Project. While its products have been studied in various clinical populations—including ADHD, MCI, stroke survivors—no formal clinical trial results supporting regulatory approval as a medical treatment have been published to date. However, ongoing research supports potential future applications as regulated digital therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumos Labs.